StockNews.com Upgrades Addus HomeCare (NASDAQ:ADUS) to “Buy”

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a hold rating to a buy rating in a report issued on Wednesday.

ADUS has been the topic of a number of other research reports. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. KeyCorp started coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Finally, Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $120.90 on Wednesday. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12. The company has a market cap of $2.19 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 2.11 and a beta of 1.02. The firm has a 50 day simple moving average of $125.76 and a 200 day simple moving average of $124.29.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 EPS. As a group, analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently bought and sold shares of the company. Quarry LP purchased a new position in shares of Addus HomeCare during the 3rd quarter valued at $28,000. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Addus HomeCare in the second quarter valued at approximately $31,000. Farther Finance Advisors LLC boosted its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares during the period. Finally, Innealta Capital LLC purchased a new position in Addus HomeCare in the 2nd quarter valued at approximately $44,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.